Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation.
Ambulation and multiple sclerosis.
The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions.
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
Predicting outcome in clinically isolated syndrome using machine learning.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors.
Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
The role of IL-6 in the expression of PD-1 and PDL-1 on CNS cells following infection with Theiler's murine encephalomyelitis virus.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Multiple sclerosis simulating brain tumor.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways.
Ocular side effects of drugs used in the treatment of multiple sclerosis.
The Diagnosis and Treatment of Optic Neuritis.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Pages
« first
‹ previous
…
471
472
473
474
475
476
477
478
479
…
next ›
last »